Theratechnologies Ownership
| THTX Stock | USD 3.16 0.02 0.64% |
Shares in Circulation | First Issued 1997-03-31 | Previous Quarter 50.4 M | Current Value 49.4 M | Avarage Shares Outstanding 42.5 M | Quarterly Volatility 25 M |
Theratechnologies | Build AI portfolio with Theratechnologies Stock |
Theratechnologies Stock Ownership Analysis
About 48.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.19. Theratechnologies had not issued any dividends in recent years. The entity had 1:4 split on the 31st of July 2023. Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company was incorporated in 1993 and is headquartered in Montreal, Canada. Theratechnologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. To find out more about Theratechnologies contact Paul Lvesque at 514-336-7800 or learn more at https://www.theratech.com.Besides selling stocks to institutional investors, Theratechnologies also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Theratechnologies' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Theratechnologies' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Theratechnologies Quarterly Liabilities And Stockholders Equity |
|
Only 1.15% of Theratechnologies are currently held by insiders. Unlike Theratechnologies' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Theratechnologies' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Theratechnologies' insider trades
Theratechnologies Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Theratechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Theratechnologies backward and forwards among themselves. Theratechnologies' institutional investor refers to the entity that pools money to purchase Theratechnologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bnp Paribas Arbitrage, Sa | 2025-03-31 | 29.8 K | Cyndeo Wealth Partners Llc | 2025-03-31 | 29.7 K | Mccormack Advisors International | 2025-03-31 | 29.2 K | Acadian Asset Management Llc | 2025-03-31 | 28.4 K | Bare Financial Services Inc | 2025-03-31 | 26.8 K | Beacon Pointe Advisors, Llc | 2025-03-31 | 26.5 K | Advisor Group Holdings, Inc. | 2025-03-31 | 26.2 K | Stonepine Capital Management Llc | 2025-03-31 | 25.8 K | Geode Capital Management, Llc | 2025-03-31 | 25.7 K | Soleus Capital Management, L.p. | 2025-03-31 | 4.8 M | Nantahala Capital Management, Llc | 2025-03-31 | 2.4 M |
Theratechnologies Outstanding Bonds
Theratechnologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Theratechnologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Theratechnologies bonds can be classified according to their maturity, which is the date when Theratechnologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Theratechnologies Stock Analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.